Nurse Practitioner in Nixon, TX Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Mrs. Maria D Ortiz, APRN, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 200 E. 2nd Ave, Nixon, TX 78140 Phone: 830-582-1100 Fax: 830-379-2325 |
News Archive
Handheld plasma-producing device can instantly kill bacteria
A group of Chinese and Australian scientists, including CSIRO, have developed a handheld, battery-powered plasma-producing device that can rid skin of bacteria in an instant. The handheld plasma flashlight could be used in ambulance emergency calls, natural disaster sites, military combat operations and many other instances where treatment is required in remote locations.
Prematics extends multi-year contract with Availity to provide e-prescribing services
Prematics, the leader in e-prescribing and care communication services, today announced a multi-year contract extension with Availity LLC, a national leader in health information exchange. Availity offers Prematics' e-prescribing services under the CarePrescribe private label. Per the terms of the agreement, Prematics will continue providing e-prescribing services to Availity through 2013, and add its Care Communication services for existing and future CarePrescribe users.
Trump vows (again) to lower drug prices but skeptics doubt much will change
President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.
UCSD Health System's hospitals and facilities ranked among 'Health Care's Most Wired'
University of California, San Diego Health System's hospitals and facilities are among "Health Care's Most Wired," according to the 14th annual survey conducted by Hospitals & Health Networks magazine.
Oncolytics Biotech receives U.K. MHRA approval for REOLYSIN combination Phase 3 trial
Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.
› Verified 2 days ago